These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 29520090)

  • 1. Non-angiogenic tumours and their influence on cancer biology.
    Donnem T; Reynolds AR; Kuczynski EA; Gatter K; Vermeulen PB; Kerbel RS; Harris AL; Pezzella F
    Nat Rev Cancer; 2018 May; 18(5):323-336. PubMed ID: 29520090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are tumours angiogenesis-dependent?
    Verheul HM; Voest EE; Schlingemann RO
    J Pathol; 2004 Jan; 202(1):5-13. PubMed ID: 14694516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumours can adapt to anti-angiogenic therapy depending on the stromal context: lessons from endothelial cell biology.
    van Kempen LC; Leenders WP
    Eur J Cell Biol; 2006 Feb; 85(2):61-8. PubMed ID: 16439306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-angiogenic tumours unveil a new chapter in cancer biology.
    Pezzella F; Gatter K
    J Pathol; 2015 Feb; 235(3):381-3. PubMed ID: 25351454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of the vascular component in growth of solid tumors: a historical review].
    Ribatti D; Vacca A
    Ann Ital Med Int; 1994; 9(2):92-5. PubMed ID: 7522501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The vascular network of tumours--what is it not for?
    Sivridis E; Giatromanolaki A; Koukourakis MI
    J Pathol; 2003 Oct; 201(2):173-80. PubMed ID: 14517833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of angiogenesis in solid tumours: an overview.
    Makrilia N; Lappa T; Xyla V; Nikolaidis I; Syrigos K
    Eur J Intern Med; 2009 Nov; 20(7):663-71. PubMed ID: 19818284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysyl oxidase-like-2 promotes tumour angiogenesis and is a potential therapeutic target in angiogenic tumours.
    Zaffryar-Eilot S; Marshall D; Voloshin T; Bar-Zion A; Spangler R; Kessler O; Ghermazien H; Brekhman V; Suss-Toby E; Adam D; Shaked Y; Smith V; Neufeld G
    Carcinogenesis; 2013 Oct; 34(10):2370-9. PubMed ID: 23828904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad targeting of angiogenesis for cancer prevention and therapy.
    Wang Z; Dabrosin C; Yin X; Fuster MM; Arreola A; Rathmell WK; Generali D; Nagaraju GP; El-Rayes B; Ribatti D; Chen YC; Honoki K; Fujii H; Georgakilas AG; Nowsheen S; Amedei A; Niccolai E; Amin A; Ashraf SS; Helferich B; Yang X; Guha G; Bhakta D; Ciriolo MR; Aquilano K; Chen S; Halicka D; Mohammed SI; Azmi AS; Bilsland A; Keith WN; Jensen LD
    Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S224-S243. PubMed ID: 25600295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-angiogenesis in cancer therapy: Hercules and hydra.
    Bellou S; Pentheroudakis G; Murphy C; Fotsis T
    Cancer Lett; 2013 Sep; 338(2):219-28. PubMed ID: 23707856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vessel co-option and resistance to anti-angiogenic therapy.
    Kuczynski EA; Reynolds AR
    Angiogenesis; 2020 Feb; 23(1):55-74. PubMed ID: 31865479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-scale mathematical modelling of tumour growth and microenvironments in anti-angiogenic therapy.
    Cai Y; Zhang J; Li Z
    Biomed Eng Online; 2016 Dec; 15(Suppl 2):155. PubMed ID: 28155728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vessel co-option in cancer.
    Kuczynski EA; Vermeulen PB; Pezzella F; Kerbel RS; Reynolds AR
    Nat Rev Clin Oncol; 2019 Aug; 16(8):469-493. PubMed ID: 30816337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor angiogenesis: biology and therapeutic prospects.
    Harris SR; Thorgeirsson UP
    In Vivo; 1998; 12(6):563-70. PubMed ID: 9891218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current concepts of tumor-induced angiogenesis.
    Paku S
    Pathol Oncol Res; 1998; 4(1):62-75. PubMed ID: 9555124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour angiogenesis, anti-angiogenic therapy and chemotherapeutic resistance.
    Mander KA; Finnie JW
    Aust Vet J; 2018 Oct; 96(10):371-378. PubMed ID: 30255577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [principal characteristics of tumor microcirculation revealed by experimental techniques in vivo].
    Vicaut E
    Therapie; 2001; 56(5):483-94. PubMed ID: 11806284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. κ Opioid receptor ligands regulate angiogenesis in development and in tumours.
    Yamamizu K; Hamada Y; Narita M
    Br J Pharmacol; 2015 Jan; 172(2):268-76. PubMed ID: 24417697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies.
    Leite de Oliveira R; Hamm A; Mazzone M
    Mol Aspects Med; 2011 Apr; 32(2):71-87. PubMed ID: 21540050
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Wu Q; Arnheim AD; Finley SD
    J R Soc Interface; 2018 Aug; 15(145):. PubMed ID: 30135261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.